JPMorgan Chase & Co’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,731
| Closed | -$76K | – | 5004 |
|
|
2019
Q3 | $76K | Buy |
2,731
+488
| +22% | +$13.6K | ﹤0.01% | 4086 |
|
|
2019
Q2 | $30K | Sell |
2,243
-631
| -22% | -$8.44K | ﹤0.01% | 4440 |
|
|
2019
Q1 | $26K | Sell |
2,874
-135
| -4% | -$1.22K | ﹤0.01% | 4446 |
|
|
2018
Q4 | $23K | Buy |
3,009
+281
| +10% | +$2.15K | ﹤0.01% | 4478 |
|
|
2018
Q3 | $57K | Buy |
2,728
+337
| +14% | +$7.04K | ﹤0.01% | 4315 |
|
|
2018
Q2 | $72K | Sell |
2,391
-2,954
| -55% | -$89K | ﹤0.01% | 4192 |
|
|
2018
Q1 | $145K | Buy |
5,345
+3,195
| +149% | +$86.7K | ﹤0.01% | 3821 |
|
|
2017
Q4 | $62K | Buy |
+2,150
| New | +$62K | ﹤0.01% | 4067 |
|
|
2017
Q3 | – | Sell |
-17,135
| Closed | -$382K | – | 4526 |
|
|
2017
Q2 | $382K | Buy |
+17,135
| New | +$382K | ﹤0.01% | 3231 |
|